viewPressure BioSciences, Inc.

Pressure BioSciences taps a seasoned financial executive as its new CFO

Daniel Shea brings more than 30 years of finance experience to the table

Most recently, Shea operated the CPA advisory firm Woodcliff Advisors LLC

Pressure BioSciences Inc (OTCMKTS:PBIO) has found its new chief financial officer (CFO) in finance veteran Daniel Shea.

Shea, 54, who joined the company effective September 13 this year, will also take on the role of senior vice president.

The new finance head brings more than 30 years' experience to the table. Since 2017, he has led Woodcliff Advisors LLC, a CPA advisory firm. While there, Shea filled CFO positions personally at public and private companies. 

READ: Pressure BioSciences' PCT technology highlighted in a pair of medical journal articles

Before that, he worked for 18 years as senior vice president at Affiliated Managers Group, an asset management holding company specializing in acquisitions. He also previously advised financial services firms at PricewaterhouseCoopers.

“We are pleased to have someone with Dan’s experience and capabilities join PBI at such an important time in our corporate evolution,” CEO Richard Schumacher said in a statement. “We believe all three of our patented technology business platforms have the potential for rapid growth over the next 12-18 months, [and] we believe total revenue in 2020 will be more than double total revenue of 2019.”

“We are fortunate to have a seasoned financial professional like Dan join us at this most important time, to lead this financial transformation.”

"It’s an exciting time to join Pressure BioSciences,” added Shea. "PBI’s unique platform technologies, worldwide customer base, growing revenue stream, and strong management team position the company well to capitalize on substantial growth opportunities across the globe."

Shares of Pressure Bio increased 4.1% to $3.07 on Tuesday.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: Pressure BioSciences, Inc.

Price: 1.43 USD

Market: OTCQB
Market Cap: $5.4 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pressure BioSciences, Inc. named herein, including the promotion by the Company of Pressure BioSciences, Inc. in any Content on the Site, the...


Full interview: Pressure BioSciences PCT instrument deemed ‘essential’ by...

Pressure BioSciences Inc (OTCMKTS:PBIO) CEO Ric Schumacher tells Proactive the Massachusetts-based company’s patented pressure cycling technology (PCT) was featured in a presentation at the Annual Meeting of the Gynecologic Cancer Society in Brazil.  Schumacher explains the company’s PCT...

on 10/04/2019

2 min read